Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5

NCT06825234 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 390

Last updated 2025-05-01

No results posted yet for this study

Summary

The aim of this study is to determine a multidimensional signature (integrating frailty and patient-reported outcomes measures (PROMs) at entry into stage 4B/5 CKD) to improve prediction of renal death (dialysis, transplantation, conservative management, death).

Conditions

  • Chronic Kidney Disease Stage 5
  • Chronic Kidney Disease Stage 4B

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06825234 on ClinicalTrials.gov